Indeed, it is known that ATR and Chk1 suppress the apoptotic response following DNA replication stress [17], and that tumors characterized by elevated levels of replicative stress, such as Myc-driven cancers, are extremely vulnerable to the pharmacological targeting of G2/M checkpoint kinases [18–23]. This evidence concerns the gene MYC and cancer.